Liver metastases
Liver metastases are commonly detected in a range of malignancies including colorectal
cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC …
cancer (CRC), pancreatic cancer, melanoma, lung cancer and breast cancer, although CRC …
The Miami international evidence-based guidelines on minimally invasive pancreas resection
HJ Asbun, AL Moekotte, FL Vissers, F Kunzler… - Annals of …, 2020 - journals.lww.com
Objective: The aim of this study was to develop and externally validate the first evidence-
based guidelines on minimally invasive pancreas resection (MIPR) before and during the …
based guidelines on minimally invasive pancreas resection (MIPR) before and during the …
Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis
C Correa-Gallego, HE Dinkelspiel… - Journal of the …, 2014 - journals.lww.com
METHODS This study adheres to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines. 28 We queried medical databases in search for …
Meta-Analyses (PRISMA) guidelines. 28 We queried medical databases in search for …
Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology
AB Benson, MI D'Angelica, DE Abbott… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …
[HTML][HTML] Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients, yet harbours
mutation-derived T cell neoantigens that are suitable for vaccines,. Here in a phase I trial of …
mutation-derived T cell neoantigens that are suitable for vaccines,. Here in a phase I trial of …
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution
BACKGROUND: This study analyzes factors associated with differences in long-term
outcomes after hepatic resection for metastatic colorectal cancer over time. STUDY DESIGN …
outcomes after hepatic resection for metastatic colorectal cancer over time. STUDY DESIGN …
Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies
Purpose: Prior molecular profiling of hepatocellular carcinoma (HCC) has identified
actionable findings that may have a role in guiding therapeutic decision-making and clinical …
actionable findings that may have a role in guiding therapeutic decision-making and clinical …
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
AB Benson 3rd, TA Abrams, E Ben-Josef… - Journal of the …, 2009 - europepmc.org
Hepatobiliary cancers are highly lethal. In 2008, approximately 21,370 persons in the United
States were estimated to be diagnosed with liver or intrahepatic bile duct cancer and 9520 …
States were estimated to be diagnosed with liver or intrahepatic bile duct cancer and 9520 …
Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention
Purpose: Various genetic driver aberrations have been identified among distinct anatomic
and clinical subtypes of intrahepatic and extrahepatic cholangiocarcinoma, and these …
and clinical subtypes of intrahepatic and extrahepatic cholangiocarcinoma, and these …
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma
Objective: To determine if the degree of blood loss during resection of hepatocellular
carcinoma (HCC) is predictive of recurrence and long-term survival. Background: Several …
carcinoma (HCC) is predictive of recurrence and long-term survival. Background: Several …